Microbiota in cancer: current understandings and future perspectives.

Although the findings did not reach statistical significance, the study still suggested that CBM588 may improve clinical outcomes in patients with metastatic renal cell carcinoma receiving nivolumab‒ipilimumab treatment 480 (Table 2 ).

also in 111,027 other papers